Highlighted transactions

Agriculture, clean tech & renewables


Deal team

Arcadia Biosciences, Inc.

Nasdaq: RKDA

Piper Sandler served as joint bookrunner on the $68 million IPO for Arcadia Biosciences, Inc. (Nasdaq: RKDA).

Client Description

Arcadia Biosciences, Inc. is a leading agricultural biotechnology trait development company with an extensive and diversified portfolio of late-stage crop productivity and product quality traits addressing multiple crops that supply the global food and feed markets.

Additional Transactions with Client

Piper Sandler served as exclusive financial advisor to Arcadia Biosciences, Inc. in May 2014 on its $33 million Series D Preferred Stock capital raise.